Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. حسب Mieke L. M. Bentvelzen (21594442)

Professional development participation is not associated with a decrease in total publication. حسب Patrick D. Brandt (4449211)

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. حسب Vincent U. Gant (9955199)

Risk-taking behavior identified by the BART decreases after acclimatization. حسب Erica C. Heinrich (6832055)

PRISMA flow chart of the screening process. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Forest plot of liver function tests. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of BUN based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of ICU Stay based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of eGFR based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

GRADE evidence profile. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Characteristics of included studies. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Sensitivity analysis for eGFR. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Sensitivity analysis for BUN. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of BUN based on surgery type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Baseline Characteristics of Included Patients. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

The trend of patient characteristics, risk factors, and risk scores. حسب Ayako Shoji (78037)

Professional development participation is not associated with a decrease in first-author publication. حسب Patrick D. Brandt (4449211)

Risk of fracture with competing risk in denosumab users versus non-users. حسب Arisa Kobayashi (4379608)

الموضوعات:

QUIPS risk of bias assessment. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"

Flow diagram of the study identification process. حسب Luz Estella Mesa (8339283)

الموضوعات: